Vaccine Weekly articles from December 2002

Vaccine Weekly archives from December 2002

New method allows mass production of dendritic cells.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Large-scale production of dendritic cells is possible through the use of a cell selector followed by culture in a sterile-bag system, according to...

Exercise and social activity influence influenza vaccine effectiveness.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Influenza vaccination generated a stronger immune response in elderly adults who maintained high levels of physical and social activity than in adults...

Herpes amplicon vectors used to develop vaccines against metastatic liver cancer.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Vaccines consisting of irradiated colon cancer cells that released granulocyte-macrophage colony-stimulating factor (GM-CSF), or GM-CSF along with the...

'Dispersin' Escherichia coli all over the gut.(Brief Article)
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- Enteroaggregative Escherichia coli (EAEC) is an emerging pathogen that causes endemic and epidemic diarrhea in developing and industrialized countries. The bacteria stick to the surface of the cells...

Vaccine study targets those already immunized as children.(against smallpox)
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- Doctors and nurses at the University of Rochester Medical Center have been chosen to lead the largest study of smallpox vaccine to date, a nationwide study of approximately 900 patients that will be...

Vaccination with BCG affects TB skin testing for up to 15 years.(tuberculosis)
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - A meta-analysis of 26 studies indicated that a previous Bacille Calmette Guerin (BCG) vaccination affects the results of tuberculin skin tests and...

Microarray technology provides insight into potential vaccine agents.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Using DNA microarray techniques, over 100 proteins having unknown functions were discovered during interactions between Neisseria meningitidis and...

DNA vaccine inhibits autoimmune disease in rat model.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- Immunologists in Israel recently presented their work on DNA vaccination against adjuvant arthritis. "Adjuvant arthritis (AA) is an autoimmune disease inducible in rats involving T-cell reactivity...

Passive immunization against beta-amyloid peptide protects CNS neurons.(central nervous system)
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- A study by researchers in Switzerland suggests that passive immunization against beta-amyloid (Abeta) peptide may protect neurons from toxicity associated with Abeta. M.H. Mohajeri and colleagues,...

New report calls for protecting at-risk civilians from anthrax.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- A panel of leading bioterrorism experts warned that the United States still lacks an articulated preparedness plan for immediate immunizations of at-risk civilians, a strategic anthrax vaccine...

Experimental vaccine induces protection against some glioblastoma cells.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- Wistar Institute researchers have shown that "[i]noculation of mice with a recombinant vaccinia virus expressing the full-length mouse wild-type p53 protein (Vp53-wt)...[induces] partial protection...

Dendritic-cell based immunotherapy may have potential against brain tumors.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- Neurologists in Japan report enhancement of antitumor immune responses in murine models of brain tumors by genetically modified dendritic cells producing Semliki Forest virus-mediated interleukin-12....

Candida-specific IgA antibodies may have limited natural protective activity.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- A recent study investigated the role of humoral immunity induced by Candida albicans infection in protection against experimental vaginal candidiasis. "Protective host defense mechanisms against...

Antibody interactivity may thwart immunity to invasive infection.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- Some antibodies to Candida albicans can act as a barrier against "the protective potential of immune serum," researchers in Italy say. "Mice immunized with heat-inactivated, whole yeast-form cells...

CMV reactivation in stem cell recipients studied.(cytomegalovirus)
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- Vaccine researchers are working on understanding the relationship of CD8+ T lymphocytes in immunity against human cytomegalovirus in allogeneic stem-cell transplants. "Human cytomegalovirus (CMV)...

Peptide extensions simply, effectively produce detoxified CT derivatives.(cholera toxin)
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- Researchers in Mexico have described a simple procedure to detoxify cholera toxin that maintains immunoadjuvanticity. "Peptides related to the heat-stable enterotoxin STa were fused to the N...

NK cell activity is dominated by US2-11-mediated HLA class I down-regulation.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- "A highly attractive approach to investigate the influence and hierarchical organization of viral proteins on cellular immune responses is to employ mutant viruses carrying deletions of various...

Transmission of ChimeriVax-DEN2 virus by vector mosquitoes is unlikely.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- Study results indicate that the live virus contained in the ChimeriVax-DEN2 vaccine (Acambis, Inc.) has limited ability to infect and replicate in Aedes aegypti and Ae. albopictus mosquitoes. "The...

Virus-like particles do not activate Langerhans cells.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- Langerhans cells are not activated by human papillomavirus (HPV) virus-like particles, report cancer researchers, who say this suggests a possible "immune escape mechanism" used by HPV. "High-risk...

Outreach efforts aim to improve pneumococcal, flu vaccine rates in primary care.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- Two studies published recently in the British Journal of General Practice focused on efforts to boost flu and pneumococcal vaccine rates in primary practices. A.N. Siriwardena and colleagues...

Hospitalized elderly patients often not vaccinated for flu, pneumonia.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- Elderly patients eligible for vaccinations against two major diseases - influenza and pneumococcal disease - are not being vaccinated during hospital admissions, according to new research. Dale W....

Survey of physicians' flu vaccine practices raises some concerns.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- University of Michigan researchers reported results of a national survey of internists and family physicians that aimed "to characterize U.S. physicians' practices regarding influenza vaccine." The...

Survey reveals most Americans underestimate severity.(of influenza)
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- While U.S. federal and state public health agencies are urging people of all ages to receive influenza vaccinations this season, a new national survey reveals that most Americans still underrate the...

No evidence vaccine causes autism.(measles, mumps and rubella vaccine)
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- A large study from Denmark offers reassuring evidence that the widely used measles, mumps and rubella vaccine does not cause autism, as some fear. Some have speculated that the measles portion of...

Aid groups say tens of thousands of Africans could die from new strain.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- Aid agencies have launched an urgent appeal for EUR10 million (US$10 million) to control a new strain of meningitis that was initially reported among pilgrims to Mecca and now threatens a large swathe...

Oral vaccine induces specific circulating mucosa-homing T cells.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- Muscosal immunization via a live, oral, bacterial vaccine has been shown by researchers in Sweden to induce antigen-specific CD4+ and CD8+ memory T cells, "almost all of which express the gut-homing...

Antitumor effects induced by dendritic cell-based immunotherapy in animal model.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- Researchers in Japan report positive results in their study of dendritic cell-based immunotherapy of pancreatic cancer in a hamster model. "Because the prognosis of patients with pancreatic cancer...

Study assesses economics of in-hospital immunization.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- A cost-benefit analysis by infectious disease specialists at Cook County Hospital, Chicago, Illinois, suggests that an inner-city hospital's emergency department may be the in-hospital location with the...

Military doctors call for reinstating adenovirus vaccination program in recruits.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- U.S. Navy medical researchers say an adenovirus immunization program urgently needs to be reinstituted for military recruits. "Outbreaks of adenovirus type 4 (Ad4) acute respiratory disease (ARD)...

Study of pneumococcal proteins supports exploration of mucosal immunization.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- Results of a study from England support earlier work in mice that suggests pneumococcal proteins may have potential as vaccine candidates against pneumococcal infection. Q.B. Zhang and colleagues,...

Feds seek public input on vaccine for children.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- The U.S. government is seeking public input before it decides whether to let a few dozen toddlers and preschoolers be vaccinated against smallpox, a study to test the best children's vaccine dose but...

Technique measures immunogenicity of TB vaccines.(tuberculosis)
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- According to a study from the United States, "Previous studies in murine and human models have suggested an important role for CD8+ T cells in host defense to Mycobacterium tuberculosis (Mtb)....

University of Kentucky researchers testing possible vaccine.(for adult diabetes)
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- University of Kentucky researchers are part of a national team testing a possible vaccine for a common type of adult diabetes. The vaccine, if successful, could eliminate or decrease the need for...

Glucans play a role in protection against yeast infections.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Beta-1,6 and beta-1,3 glucan appear to prevent serum from immunized mice from conferring protection against Candida albicans in naive animals,...

Interleukin-12 an unexpected suppressor in dendritic cell vaccine.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Data from a dendritic cell vaccine study have yielded some unexpected results, scientists report. Interleukin (IL)-12 diminishes rather than enhances the...

New HIV vaccine holds promise of global effectiveness.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Clinical tests have begun of a novel vaccine directed at the three most globally important HIV subtypes, or clades. Developed by scientists at the Dale and Betty Bumpers Vaccine Research Center...

Cyclophilin B peptide fails in phase 1 lung cancer trial.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Phase 1 clinical trial results revealed that a cyclophilin B peptide vaccine was safe when given to lung cancer patients, but did not elicit a...

Genetic vaccines protect mice against Chagas disease.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Mice immunized with plasmids coding for Trypanosoma cruzi antigens along with plasmids coding for interleukin-12 and granulocyte-macrophage...

Herpesvirus vaccine aided by calcium phosphate nanoparticle adjuvant.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Calcium phosphate nanoparticles (CAP) acted as a potent adjuvant in the mucosal delivery of a vaccine directed against of herpes simplex virus type 2...

Additional nutrients improve immune response to influenza vaccination in the elderly.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Elderly adults who took a complete nutritional supplement for 7 months mounted stronger antibody responses to influenza immunization compared with...

VaxGen's phase III trial in Thailand clears final scheduled safety review.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- The independent board that oversees VaxGen, Inc.'s clinical trials completed the final safety and conduct review of the company's phase III trial in Thailand and once again concluded that the study was...

Tuberculin response higher in BCG-vaccinated children with allergic diseases.(bacillus Calmette-Guerin)
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Among bacillus Calmette-Guerin (BCG)-vaccinated children, those with allergies mount a higher response to tuberculin than those who are nonallergic, a recent study found. "The prevalence of...

Study links vaccine to higher stroke risk.(amyloid beta vaccine)
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- In what may be a new warning sign about a once-promising therapy for Alzheimer disease, researchers report that in animal studies a vaccine that clears the brain of toxic deposits also tends to double...

Nasal immunization with heat shock proteins has therapeutic potential.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Results of a study in mice suggest nasal immunization with heat shock proteins could be a new approach to treating atherosclerosis. According to researchers, "Increasing evidence supports the...

Oral tolerance with HSP 65 attenuates Mtb- and high-fat diet-induced lesions.(heat shock protein)
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Researchers in Israel conducted a study of the "efficacy of oral tolerance with heat shock protein (HSP) 65 in two apparently nonoverlapping models of murine atherosclerosis." Providing background...

Tumor vaccine raises antigen-specific response in gastric cancer patients.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Medical collaborators in Japan and Sweden have completed a phase I trial of peptide-pulsed dendritic cells in gastric cancer patients. Scientists have...

Activation of tumor-reactive CTL by weak agonists could be new design approach.(cytotoxic T lymphocytes)
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- University of Texas, M.D. Anderson Cancer Center researchers have been working on a new angle in designing cancer vaccines. A. Castilleja and colleagues explained: "To design side chain variants...

DNA fusion vaccine components induce protective CTL against a single epitope.(cytotoxic T lymphocytes)
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- DNA fusion vaccine components were able to induce protective cytotoxic T cells against a single epitope of a tumor antigen, according to a recent study. "DNA vaccines can activate immunity against...

Leukapheresis products are potential sources of quantities of dendritic cells.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Researchers in Australia have suggested what may be a practical way to obtain cells for studies of dendritic cell-based vaccines. F.J. Radcliff and colleagues, Royal Children's Hospital, described...

Prevention is the best strategy against postherpetic neuralgia.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Pain management specialists in England emphasize the necessity of educating both the public and health care personnel about early recognition and management of postherpetic neuralgia. ...

Immunization with Hap adhesin found protective in murine study.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Washington University researchers suggest intranasal immunization with the protein Hap adhesin formulated with mutant cholera toxin may help prevent nontypeable Haemophilus influenzae disease. ...

Distinct mechanisms of intestinal priming lead to cross-protection.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- A study of the mechanisms of immunological cross-protection has shown that intestinal priming promotes protection of the upper and lower respiratory tracts through distinct mechanisms. "A main...

Study: Memory CD8+ T cells are more resistant to apoptosis than naive cells.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Emory University vaccine researchers have demonstrated, in mice, that naive and memory CD8+ T cells have differing sensitivities to apoptosis. They think their findings may be applicable to designing...

CDC reports not enough seniors getting flu shots.(U.S. Centers for Disease Control and Prevention )(Brief Article)
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Fewer than two-thirds of the nation's senior citizens are getting vaccinated against flu and pneumonia - well short of the government's goal of 90% by 2010, the U.S. Centers for Disease Control and...

Shire announces vaccines alliance.(Shire Pharmaceuticals Group PLC)(Brief Article)
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Shire Pharmaceuticals Group, plc, announced that it has entered into a commercial agreement with Berna Biotech, AG, of Switzerland. Under the agreement, Shire will manufacture and supply its...

Trivalent, cold-adapted flu vaccine well-tolerated by preschool-aged children.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- The trivalent, cold-adapted influenza vaccine (CAIV-T) appears safe in children under age 6, according to a recent study. Baylor College of Medicine researcher P.A. Piedra and colleagues conducted...

Cell fusion vaccine approach being tested.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Genzyme Molecular Oncology (GZMO) launched a new clinical trial in kidney cancer that uses an innovative vaccine made from combining the patient's own cancer cells with powerful, immune-stimulating...

New findings in vaccine development announced at international conference.(Third Pan-African Malaria Conference of the Multilateral Initiative on Malaria )
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- The largest malaria conference in the world, the Third Pan-African Malaria Conference of the Multilateral Initiative on Malaria (MIM) recently convened in Tanzania; it was organized by the U.S....

T-cell clones shrink tumors.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- A preliminary clinical trial suggests that armies of T cells generated in the lab can be injected into patients to halt the spread of cancerous tumors. The study, conducted by Dr. Cassian Yee, a...

Therapeutic polyvalent vaccine prolongs overall survival.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Canvaxin, a therapeutic polyvalent vaccine (PV), has been shown to significantly improve overall survival of patients with metastatic melanoma. The aim of D.L. Morton and colleagues, St. John's...

Antigenic relationships compared among six viral genotypes.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Virologists in Sweden reported the results of an antigenic comparison of mumps virus genotypes A, C, D, G, H, and I. These six had been "genotyped on the basis of the small hydrophobic protein...

Antiaggregating antibodies: New approach to treating conformational diseases?(prion-related diseases)
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Could Alzheimer disease be prevented with a vaccine? Not in the immediate future, but it seems that research results are pointing to the potential of immunotherapy for such conditions as Alzheimer's...

Rabbit oral papillomavirus appears best choice for developing HPV vaccine.(human papillomavirus)
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- A comparison of animal papillomaviruses to the human variety suggests rabbit oral papillomavirus is best suited for study of the "life cycles of mucosal papillomavirus types and for the development of...

U.N. campaign under way to vaccinate 60 million African children.(polio)(Brief Article)
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- An immunization campaign to vaccinate 60 million children under 5 years old in 16 West African countries is under way as part of a global campaign to eradicate polio, the virus that cripples children,...

Study suggests RSV vaccine only for premature neonates with lung disease.(respiratory syncytial virus )
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- A cost-benefits analysis suggests that of babies discharged from neonatal intensive care units, in Northern Ireland at least, only those with chronic lung disease who are very premature should receive...

Vaccine proves protective in preliminary studies.(sepsis)
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- A group of researchers from the Scripps Research Institute (TSRI) have designed a vaccine that might be used to protect against the pernicious consequences of severe sepsis, an acute and often deadly...

Targeted vaccinations could be effective intervention against deliberate attack.(smallpox )
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Targeted vaccination of the close contacts of infected individuals following a smallpox outbreak could rival the effectiveness of mass vaccination, given a sufficiently high level of immunity within...

Combination of inactivated tumor cells and GM-CSF effective against neuroblastomas.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Treatment with irradiated tumor cells plus an infusion of granulocyte-macrophage colony-stimulating factor inhibited the growth of neuroblastoma...

Streptococcus pneumoniae antigens are good candidates for mucosal vaccines.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Results of in vitro studies indicate that virulence proteins of Streptococcus pneumoniae are strongly antigenic in the upper respiratory tract of...

Strong results from Australian cancer vaccine trials.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- Australian Cancer Technology, Ltd. (AustCancer) (ACU) has announced achievement of a major milestone in phase Ib/IIa clinical trials of its Pentrix anticancer vaccine at St Vincent's Hospital, Sydney....

Carcinoembryonic antigen expressed by head and neck cancer tumors.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Many head and neck tumors were found to express human carcinoembryonic antigen (CEA), providing a potential target for vaccine therapy of head and...

Major vaccine trial launched in women.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- A pivotal efficacy trial of an experimental vaccine designed to prevent genital herpes in women has begun enrolling volunteers. The study will determine the vaccine's ability to prevent genital...

Airline flight crews benefit from influenza vaccination.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Vaccination against influenza is safe and reduces sick days in civilian flight crew personnel, researchers in Brazil find. "Approximately 10% of...

University of Alabama to initiate phase I trial of HER-2 vaccine.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- Galenica Pharmaceuticals announced that the University of Alabama at Birmingham Comprehensive Cancer Center (UAB-CCC) is beginning a National Cancer Institute-sponsored phase I human clinical trial of...

PAHO analyzes social, economic and epidemiological trends.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- Dengue has become a major international public health problem, with a dramatic expansion in recent decades. The mosquito that transmits dengue is found in nearly 100 tropical countries. Every...

AIDSVAX developer releases third-quarter financial results.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- VaxGen, Inc., (VXGN) announced a net loss of $7.8 million, or 54 cents per share excluding noncash charges, for the third quarter ended September 30, 2002, compared with a net loss of $6.2 million, or...

Allovectin-7 developer announces third-quarter 2002 financial results.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- Vical, Inc., (VICL) reported revenues of $2.5 million for the third quarter which ended September 30, 2002, compared with revenues of $2.4 million for the third quarter of the prior year. Revenues...

Cost, staff reduction plans underway for vaccine maker.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- Avax Technologies, Inc., (AVXT) announced its financial results for the quarter and 9 months ended September 30, 2002. The losses for the 9- and 3-month periods ended September 30, 2002 were...

Qiagen reports third quarter net sales increased 21%.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- Qiagen, N.V., (QGENF) announced the results of operations for its third quarter and 9-month period ended September 30, 2002. The company reported that consolidated net sales for its third quarter...

Study: Remune antigen with CpG ODN may offer HIV protection.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- The Immune Response Corp. (IMNRD) announced the final results of a study at McMaster University Health Sciences Centre suggesting that use of Remune antigen in combination with oligonucleotides...

Vaccine and immunotherapy adjuvant technology presented at IDD conference.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- PRIMABioMed, Ltd., a cancer and immunotherapy research and therapeutic development company, presented its vaccine and immunotherapy adjuvant technology, named DCtag, at the recent Innovative Drug...

Researcher summarizes the promise of dendritic cells.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- In a new report, Jacques Banchereau, PhD, director of the Baylor Institute for Immunology Research in Dallas, summarizes the current status of knowledge of dendritic cells, a class of white blood cells...

AMA says there's still time to get vaccinated against the flu.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- This year's flu season will soon be making its way across the nation, and the American Medical Association is reminding people that the best defense is to get immunized against the flu as soon as...

Preservative-free influenza vaccine available for pediatric use.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- Aventis Pasteur announced that the company has begun shipping Fluzone Preservative-free: Pediatric Dose, influenza virus vaccine to customers. The company received Food and Drug Administration...